APLS FY 2019 Earnings — Apellis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

APLSApellis Pharmaceuticals, Inc.

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$595,449

Operating Income

-$288M

Net Income

-$305M

EPS (Diluted)

$-4.98

Cash Flow

Operating Cash Flow

-$211M

Free Cash Flow

-$213M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$389M

Total Liabilities

$355M

Stockholders' Equity

$34M

Cash & Equivalents

$352M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$595,449	-$128M	+99.5%
Operating Income	-$288M	-$128M	-125.1%
Net Income	-$305M	-$128M	-139.0%